# Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment

> **NCT01864512** · — · WITHDRAWN · sponsor: **Shandong University**

## Conditions studied

- Immune Thrombocytopenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01864512
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible patient was enrolled.
- **Last updated:** 2016-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01864512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01864512, "Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01864512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*